Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
Xinrong Zhang(Tianjin Medical University), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Jimmy Che‐To Lai(Chinese University of Hong Kong), Alice P.S. Kong(Chinese University of Hong Kong), Johnny T. K. Cheung(Chinese University of Hong Kong), Vicki Wing‐Ki Hui(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Huapeng Lin(Zhejiang University), Henry Lik‐Yuen Chan(Radiant Research (United States)), Yee‐Kit Tse(Chinese University of Hong Kong), Terry Cheuk‐Fung Yip(Chinese University of Hong Kong)
Cited by 54
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777